{
    "id": 23003,
    "fullName": "CCDC88A - ALK",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CCDC88A-ALK results from the fusion of CCDC88A and ALK, leading to increased cell proliferation and activation of Erk1/2 in culture, and tumorigenesis in mouse models (PMID: 31554817). CCDC88A-ALK has been identified in low and high-grade gliomas (PMID: 31554817), and ependymoma-like glioma (PMID: 25795305).",
            "references": [
                {
                    "id": 5744,
                    "pubMedId": 25795305,
                    "title": "Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25795305"
                },
                {
                    "id": 16496,
                    "pubMedId": 31554817,
                    "title": "Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31554817"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 55704,
        "geneSymbol": "CCDC88A",
        "terms": [
            "CCDC88A",
            "APE",
            "GIRDIN",
            "GIV",
            "GRDN",
            "HkRP1",
            "KIAA1212",
            "PEHO",
            "PEHOL"
        ]
    },
    "variant": "CCDC88A - ALK",
    "createDate": "06/06/2016",
    "updateDate": "12/03/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 18992,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Xalkori (crizotinib) reduced viability of transformed human astrocytes expressing CCDC88A-ALK in culture (PMID: 31554817).",
            "molecularProfile": {
                "id": 23674,
                "profileName": "CCDC88A - ALK"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3069,
                "name": "astrocytoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16496,
                    "pubMedId": 31554817,
                    "title": "Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31554817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 18991,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Zykadia (ceritinib) reduced viability of transformed human astrocytes expressing CCDC88A-ALK in culture (PMID: 31554817).",
            "molecularProfile": {
                "id": 23674,
                "profileName": "CCDC88A - ALK"
            },
            "therapy": {
                "id": 789,
                "therapyName": "Ceritinib",
                "synonyms": null
            },
            "indication": {
                "id": 3069,
                "name": "astrocytoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16496,
                    "pubMedId": 31554817,
                    "title": "Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31554817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23674,
            "profileName": "CCDC88A - ALK",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}